Condition 1: Asherman Syndrome. Condition 2: Endometrial Atrophy. Female infertility of uterine origin Female infertility of uterine origin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Infertile patients referred to the Fatemieh infertility department of Hamadan University of Medical Sciences who suffer from Asherman syndrome or thin endometrium and did not respond to common treatments such as hormone therapy and surgery.
Exclusion criteria
Exclusion criteria: Patients with cardiovascular, renal disorders Patients with Syphilis, Hepatitis, AIDS Patients with husband infertility factor Endometrial thickness more than 7 mm
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness. Timepoint: Before transplantation and every month for one year after cell therapy. Method of measurement: Ultrasonography.;Menstruation. Timepoint: Monthly for one year after transplantation. Method of measurement: Number of menstruation days and used pads.;Fertility percent. Timepoint: For one year following transplantation. Method of measurement: Routine pregnancy tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| FSH. Timepoint: Before and three months following cell transplantation. Method of measurement: Blood sampling.;LH. Timepoint: Before and three months following cell transplantation. Method of measurement: Blood sampling.;Endometrial adhesion. Timepoint: Before and three month after cell transplantation. Method of measurement: Ultrasonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences